PharmaCom BioVet, Inc. Announces Direct Injection Liquid Brachytherapy Planned For Their Canine Cancer Treatment Centers

RALEIGH, NC -- October 21, 2008 - PharmaCom BioVet, Inc. (PINKSHEETS: PHMB). PharmaCom BioVet, Inc. is pleased to announce its plans to explore the ground-breaking Liquid Brachytherapy System for the direct injection of therapeutic radioisotopes* for use within its Canine Cancer Treatment Centers.
MORE ON THIS TOPIC